Alberta Investment Management Corp (AIMCo)’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-34,600
Closed -$588K 1081
2020
Q3
$588K Hold
34,600
0.01% 783
2020
Q2
$806K Buy
+34,600
New +$501K 0.01% 717
2020
Q1
Sell
-15,000
Closed -$147K 1069
2019
Q4
$147K Sell
15,000
-23,100
-61% -$217K ﹤0.01% 886
2019
Q3
$362K Buy
+38,100
New +$402K ﹤0.01% 794
2019
Q2
Sell
-20,600
Closed -$363K 1029
2019
Q1
$363K Sell
20,600
-18,000
-47% -$299K ﹤0.01% 803
2018
Q4
$670K Sell
38,600
-11,000
-22% -$188K 0.01% 637
2018
Q3
$739K Sell
49,600
-35,300
-42% -$547K 0.01% 669
2018
Q2
$1.35M Buy
84,900
+53,300
+169% +$795K 0.01% 527
2018
Q1
$449K Buy
+31,600
New +$468K ﹤0.01% 693
2017
Q3
Sell
-38,800
Closed -$611K 829
2017
Q2
$611K Buy
+38,800
New +$559K 0.01% 619

Other funds holding VIVO

Alberta Investment Management Corp (AIMCo)'s VIVO Position: Q4 2020 in Review

Alberta Investment Management Corp (AIMCo) sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 34,600 shares — an estimated $588K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in VIVO in Q2 2017 and held it in 10 quarters. The position peaked at $1.35M in Q2 2018. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 34,600 Meridian Bioscience Inc shares in Q4 2020, an estimated $588K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Meridian Bioscience Inc in Q2 2017 and held it in 10 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Meridian Bioscience Inc position peaked at $1.35M in Q2 2018.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2020, filed 16 Feb 2021.